Avanos Medical Inc (AVNS)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$11.85

Buy

$13.00

arrow-down$-0.22 (-1.75%)

Halyard Health Inc is a medical technology company which provides healthcare supplies and solutions that target the prevention of healthcare associated infections. Its business segments include Surgical and Infection Prevention and Medical Devices.
Prices updated at 01 May 2025, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.63%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Gary D. Blackford
CEO
Mr. David C. Pacitti
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
2,227
Head office
5405 Windward Parkway
Alpharetta
United States
30004
mobile
+1 844 428-2667
letter
Investor.Relations@Avanos.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. David C. Pacitti
Chief Executive Officer
-----
Mr. Gary D. Blackford
Chairman of the Board
0.21m--0.40m-
Mr. Patrick J. O'Leary
Independent Director
0.10m--0.29m-
Dr. Julie A. Shimer, PhD
Independent Director
0.10m--0.29m-
Mr. Warren J. Machan
Interim Chief Financial Officer
0.33m--0.33m-
Ms. Indrani Lall Franchini, J.D.
Independent Director
0.05m--0.14m-
Mr. Kerr W. Holbrook
Senior Vice President and Chief Commercial Officer
0.50m--2.20m-
Ms. Mojirade James
Senior Vice President, General Counsel and Secretary
0.47m--1.91m-
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
0.09m--0.28m-
Mr. John Joseph Hurley
Principal Accounting Officer and Controller
-----
Mr. Sigfrido Delgado
Senior Vice President, Integrated Supply Chain
0.30m--0.81m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc7,151,8270.00231046391.48483330 Apr 202515.55
Vanguard Group Inc5,339,7780.00148194760.36606930 Apr 202511.61
BlackRock Fund Advisors4,862,7230.32445-17452-30 Apr 202510.57
T. Rowe Price Investment Management,Inc.3,011,3120.0295764426727.21819830 Apr 20256.55
RGM Capital LLC2,986,5191.96401-184936-5.83126730 Apr 20256.49

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
03 Dec 2024-Mr. Michael C. Greiner--200,898--
29 Oct 2024-Mr. Michael C. Greiner--190,898--
05 Sep 2024-Mr. John Joseph Hurley--9,646--
22 Jul 2024-Ms. Mojirade James21.9915,04170,313--
18 Mar 2024-Mr. Joseph F. Woody--453,810--
18 Mar 2024-Mr. Joseph F. Woody19.09135,444446,715--
18 Mar 2024-Mr. Joseph F. Woody19.09509,130420,045--
18 Mar 2024-Mr. Michael C. Greiner--155,714--
18 Mar 2024-Mr. Michael C. Greiner19.09135,787146,709--
18 Mar 2024-Mr. Michael C. Greiner19.0936,118153,822--
18 Mar 2024-Mr. Kerr W. Holbrook--89,727--
18 Mar 2024-Mr. Kerr W. Holbrook19.0954,21686,131--
18 Mar 2024-Mr. Kerr W. Holbrook19.0914,43288,971--
14 Mar 2024-Mr. Michael C. Greiner19.1515,473151,605--
14 Mar 2024-Mr. Michael C. Greiner19.1172,618155,695--
14 Mar 2024-Mr. Michael C. Greiner19.1213,652154,981--
14 Mar 2024-Mr. Michael C. Greiner19.1342,679152,750--
14 Mar 2024-Mr. Michael C. Greiner19.146,450152,413--
14 Mar 2024-Mr. Michael C. Greiner19.162,108151,495--
11 Mar 2024-Dr. Julie A. Shimer, PhD19.859,92550,090--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.